Mirrabooka Flags Attractive Small- and Mid-Cap Valuations at AGM

• Mirrabooka Investments reviewed FY26 profit of $13 million, versus $7.9 million previously, at its October 5, 2026 annual general meeting.
• The final dividend remained 6.5 cents per share. A 3-cent special dividend brought annual dividends to 14 cents per share, fully franked.
• Portfolio underperformance reflected divergence between resources and industrials, alongside valuation declines across several growth-oriented holdings.
• New portfolio additions included Ramsay Health Care, ASX and Cochlear, following share-price weakness.
• Shares traded at a discount to net asset backing of 90 cents in the dollar as of October 5, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirrabooka Investments Limited published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.